Portland, oregon
May 19-20, 2023
Psycon Psychedelic Convention
Lamar Odom will be coming in-person to share live and on-stage his life-changing experiences with ketamine and ibogaine.Â
Speaker Bio: Â
Lamar Odom is a two-time NBA champion, an NBA Sixth Man of the Year, and an Olympic gold medalist who credits psychedelic medicine with saving his life. Odom’s journey to redemption from addiction and other mental health issues is chronicled in the documentary Lamar Odom Reborn directed by Zappy Zapolin. His life-changing experiences with ketamine and ibogaine inspired Odom to begin advocating for psychedelics worldwide; he will share his incredible story at PsyCon Portland in a compelling can’t-miss talk for attendees.
Presentation Abstract: Trying to break into the retreat industry without a lot of capital? Growth IS possible! Digital advertising has become much, much more difficult in the last 5 years – privacy, ad blockers, and ever-increasing competition for eyeballs against, in the case of some digital outlets, DECLINING users and inventory. What’s a host to do? Join me and other digital experts to examine the challenges posed by various digital media strategies, and learn about cost-effective customer acquisition.
Speaker Bio: Jon has spent 15 years transforming businesses at the forefront of digital marketplaces, identity, and consumer insights, and is now leading the growth of Frshminds.com, a leading source of information and leads in the growing global psychedelic retreat market. Yet another reformed cannabis industry vet, Jon drove the transformation of Lift & Co into Canada’s leading source of industry data. A reformed strategy consultant, Jon holds an MBA from the University of Toronto and wants to spend the next 10 years hosting AirBnB’s on a beach somewhere.
Presentation Abstract: Learn what Borderline Personality Disorder is, go over why folks with this diagnosis have traditionally been left out of the research with psychedelics, review the current research available, and learn how psychedelics could be beneficial to this population when done safely.Â
Speaker Bio: Â
Jenna has a passion for helping folks with Borderline Personality Disorder (BPD) using psychedelics. With a BA in Psychology and MA in counseling, she practiced therapy for 15 years in a variety of settings and specialized in treating BPD and PTSD. After years of unofficially helping clients integrate their psychedelic experiences and seeing how helpful this medicine was for clients (and herself), she completed a certification course to become a psychedelic integration coach. She is now the co-owner of Inner Dimensions Integration, LLC where she has the honor of turning her passion into a career.
Presentation Abstract:
Oregon’s Measure 109 allowed the first regulated psilocybin facilitator training programs to launch in late 2022. Just as psilocybin facilitators are beginning to get licensed and start practicing in Oregon, other states are building similar regulatory frameworks. The need for education and professional standards is clear and a number of governmental agencies and independent organizations are involved in meeting it. This talk will give an overview of education requirements and how education programs are regulated in Oregon, discuss professional organizations and efforts at creating accreditation systems, and frame the key questions for the sustainable growth of robust training programs in states where similar opportunities are soon to open.
Â
Speaker Bio:
Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder, and has served as a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, psilocybin-assisted treatment of treatment resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted psychotherapy. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings.Â
Presentation Abstract:
From psychedelic facilitators and product manufacturers to service centers and testing laboratories, opportunities abound in Oregon’s emerging psilocybin industry. Entrepreneurs, advocates, healthcare professionals and the psychedelic-curious should attend this session to learn the ins and outs of the Oregon Psilocybin Services regulations and licensing process—and for helpful tips to get you on the path to success in this exciting new field.
Speaker Bio:
Yolanda Clarke is an attorney at Vicente LLP, the nation’s leading cannabis and psychedelics law firm. As part of the firm’s Psychedelics & Emerging Therapies team, she assists those working and interested in the psychedelics field with licensing and regulatory compliance. Since 2016, Yolanda has led and assisted with cannabis licensing projects across the U.S. in California, Colorado, Florida, Louisiana, Maryland, Michigan, Missouri, New Jersey, Pennsylvania, Mississippi, Ohio, New York, Illinois, Utah, Iowa, Georgia, and Alabama, as well as internationally in Canada. With more than 40 licenses obtained for clients, she is highly knowledgeable in all aspects of the licensing process.Â
